トピックス別レポート一覧 その他の市場調査レポート
- 医療
-
- その他
- Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Drugs In Development, 2022, provides an ov…
- このレポートの詳細ページはこちら
- Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Drugs In Development, 2022, provides an …
- このレポートの詳細ページはこちら
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide End-Stage…
- このレポートの詳細ページはこちら
- Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Irritable Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Drugs In Develop…
- このレポートの詳細ページはこちら
- Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Coagulation Factor XI (Plasma Thromboplastin Ante…
- このレポートの詳細ページはこちら
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Estrogen Receptor Beta (ER Bet…
- このレポートの詳細ページはこちら
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide…
- このレポートの詳細ページはこちら
- Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Drugs In Development, 2022, provid…
- このレポートの詳細ページはこちら
- Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2022, provides…
- このレポートの詳細ページはこちら
- Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2022, provides an overview…
- このレポートの詳細ページはこちら
- Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma (…
- このレポートの詳細ページはこちら
- Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carc…
- このレポートの詳細ページはこちら
- Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Drugs In…
- このレポートの詳細ページはこちら
- Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In Development, 2022, provides an …
- このレポートの詳細ページはこちら
- Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Drugs In Development, 2022, provides an ov…
- このレポートの詳細ページはこちら
- 感染性呼吸器疾患診断の世界市場規模調査＆予測、製品タイプ別（機器、消耗品、サービス）、サンプルタイプ別（唾液、鼻咽頭スワブ（NPS）、前鼻腔、血液、その他）、技術別（Immunoassay,分子診断、微生物学、その他の技術）、アプリケーション別（COVID-19、インフルエンザ、呼吸同期ウイルス（RSV）、結核、レンサ球菌検査、その他の呼吸器疾患検査）、地域別分析、2022-2029年
- Global Infectious Respiratory Disease Diagnostics Market Size study & Forecast, by Product Type (Instruments, Consumables, Services), by Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), by Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), by Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Other Respiratory Disease Testing) and Regional Analysis, 2022-2029
- 価格 US$ 4,950 ｜ Bizwit Research & Consulting LLP ｜ 2022年10月 ｜ 英文レポート
- Global Infectious Respiratory Disease Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Infectious respiratory disease is caused …
- このレポートの詳細ページはこちら
- テンポラリーペーシングリードの世界市場規模調査、製品タイプ別（ユニポーラテンポラリーペーシングリード、バイポーラテンポラリーペーシングリード）、技術別（経皮ペーシング、経静脈ペーシング、心外膜ペーシング）、エンドユーザー別（病院、外科外来、心臓カテーテルセンター）、地域予測2022-2028年
- Global Temporary Pacing Leads Market Size study, By Product Type (Unipolar Temporary Pacing Leads, Bipolar Temporary Pacing Leads), By Technique (Transcutaneous Pacing, Transvenous Pacing, Epicardial Pacing), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Centers) , and Regional Forecasts 2022-2028
- 価格 US$ 4,950 ｜ Bizwit Research & Consulting LLP ｜ 2022年10月 ｜ 英文レポート
- Global Temporary Pacing Leads Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The temporary cardiac pacing lead is two electrodes with a smal…
- このレポートの詳細ページはこちら
- 動物用遠心分離機の世界および米国における市場インサイト、2028年までの予測
- Global and United States Veterinary Centrifuges Market Insights, Forecast to 2028
- 価格 US$ 4,350 ｜ QYResearch ｜ 2022年11月 ｜ 英文レポート
- Market Analysis and Insights: Global and United States Veterinary Centrifuges MarketThis report focuses on global and United States Veterinary Centrifuges market, also covers the segmentation data of other regions in regional level and county level.Due to…
- このレポートの詳細ページはこちら
- ろ過・分離市場：タイプ別（気体・液体、空気）、エンドユーザー別（工業プロセス、HVAC、ライフサイエンス、上下水道、輸送）。世界の機会分析および産業予測、2021-2031年
- Filtration and Separation Market By Type (Gas And Liquid, Air), By End-User (Industrial Process, HVAC, Life Sciences, Water And Wastewater, Transportation): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,730 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- The global filtration and separation market was valued at $98,128.1 million in 2021, and is projected to reach $152,051.8 million by 2031, registering a CAGR of 4.4% from 2022 to 2031. The filtration & separation system refers to the water and air filters…
- このレポートの詳細ページはこちら
- 炎症性腸疾患治療薬市場：タイプ別（潰瘍性大腸炎、クローンズ病）、薬物クラス別（TNF阻害剤、コルチコステロイド、アミノサリチル、JAK阻害剤、抗インテグリン、IL阻害剤、その他）、流通チャネル別（病院薬局、ドラッグストアと小売薬局、オンラインショップ）。世界の機会分析および産業予測、2021-2031年
- Inflammatory Bowel Disease Drugs Market By Type (Ulcerative Colitis, Crohns Disease), By Drug Class (TNF inhibitors, Corticosteroids, Aminosalicylates, JAK inhibitors, Anti-integrin, IL inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy, Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,820 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- The global inflammatory bowel disease drugs market was valued at $20,988 million in 2021 and is projected to reach $34.513.56 million by 2031 registering a CAGR of 5.1% from 2022 to 2031.Inflammatory bowel disease is a group of disorders that causes chron…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る
